Skip to content

The study on optimization of unrelated umbilical cord blood transplanting conditioning regimen for pediatric/adolescents Acquired Aplastic Anemia

The study on optimization of unrelated umbilical cord blood transplanting conditioning regimen for pediatric/adolescents Acquired Aplastic Anemia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088868
Enrollment
Unknown
Registered
2024-08-28
Start date
2024-03-04
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aplastic anemia

Interventions

The group of Mini-ATG:To carry out allogeneic umbilical cord blood stem cell transplantation with miniATG+TBI+FLU+CTX as conditioning regimen for the treatment of acquired anemia

Sponsors

Institute of Hematology, Blood Disease Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1) Age 18 years both male and female 2) Bone marrow morphology and biopsy confirmed acquired aplastic anemia with indication for HSCT 3) ECOG score = 2 4) Informed consent of the children legal guardian. Eligible children in this study were required to meet the above 4 criteria Eligible children in this study were required to meet the above 4 criteria.

Exclusion criteria

Exclusion criteria: 1) Severe organ dysfunction or disease 2) HIV-positive, active hepatitis Bactive hepatitisC or active tuberculosis with other potentially life-threatening serious infections 3) Congenital bone marrow failure syndromes 4) PNH cloning 5) Myelodysplastic syndrome 6) Any other conditions recognized by the researchers as unsuitable for participation in this study

Design outcomes

Primary

MeasureTime frame
acute GVHD rate;engraftment rate ;

Secondary

MeasureTime frame
Neutrophil engraftment time;platelet engraftment time;graft failure rate;chronic GVHD rate;overall survival time;disease-free survival time;event-free survival time;

Countries

China

Contacts

Public ContactZhu Xiaofan

Institute of Hematology, Blood Disease Hospital, Chinese Academy of Medical Sciences

xfzhu@ihcams.ac.cn+86 137 5209 0418

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026